These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 22334592)
1. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells. Chadalapaka G; Jutooru I; Safe S Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592 [TBL] [Abstract][Full Text] [Related]
2. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063 [TBL] [Abstract][Full Text] [Related]
3. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Jutooru I; Chadalapaka G; Sreevalsan S; Lei P; Barhoumi R; Burghardt R; Safe S Exp Cell Res; 2010 Aug; 316(13):2174-88. PubMed ID: 20435036 [TBL] [Abstract][Full Text] [Related]
5. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786 [TBL] [Abstract][Full Text] [Related]
6. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10. Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812 [TBL] [Abstract][Full Text] [Related]
7. Curcumin decreases specificity protein expression in bladder cancer cells. Chadalapaka G; Jutooru I; Chintharlapalli S; Papineni S; Smith R; Li X; Safe S Cancer Res; 2008 Jul; 68(13):5345-54. PubMed ID: 18593936 [TBL] [Abstract][Full Text] [Related]
8. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors. Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105 [TBL] [Abstract][Full Text] [Related]
9. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967 [TBL] [Abstract][Full Text] [Related]
10. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer. Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354 [TBL] [Abstract][Full Text] [Related]
11. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters. Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804 [TBL] [Abstract][Full Text] [Related]
13. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells. Sreevalsan S; Safe S Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632 [TBL] [Abstract][Full Text] [Related]
14. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920 [TBL] [Abstract][Full Text] [Related]
15. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species. Takeuchi H; Taoka R; Mmeje CO; Jinesh GG; Safe S; Kamat AM Urol Oncol; 2016 Aug; 34(8):337.e11-8. PubMed ID: 27038699 [TBL] [Abstract][Full Text] [Related]
16. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840 [TBL] [Abstract][Full Text] [Related]
17. Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Chadalapaka G; Jutooru I; Burghardt R; Safe S Mol Cancer Res; 2010 May; 8(5):739-50. PubMed ID: 20407012 [TBL] [Abstract][Full Text] [Related]
18. Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs. Safe SH; Prather PL; Brents LK; Chadalapaka G; Jutooru I Anticancer Agents Med Chem; 2012 Dec; 12(10):1211-20. PubMed ID: 22583404 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. Jutooru I; Chadalapaka G; Lei P; Safe S J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607 [TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Nair V; Pathi S; Jutooru I; Sreevalsan S; Basha R; Abdelrahim M; Samudio I; Safe S Carcinogenesis; 2013 Dec; 34(12):2870-9. PubMed ID: 23803693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]